RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Clinical trials for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED explained in plain language.

Never miss a new study

Get alerted when new RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear

Sign up with your email to follow new studies for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1

New immune therapy trial aims to tame Tough-to-Treat lymphoma

Disease control Not yet recruiting

This study is testing a new combination of drugs for adults with an aggressive type of lymphoma (DLBCL) that has returned or not responded to prior treatment. The goal is to see if this therapy can effectively shrink the cancer and prepare patients for a stem cell transplant, a p…

Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED

Get alerted when new RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear

New immune therapy trial aims to tame Tough-to-Treat lymphoma